• Sustained release formula
• Glucose metabolism
• Metal chelation
Serving Size: 1 Capsule
N-Acetyl-L-Cysteine … 400 mg
R( α )lipoic acid (sodium salt)* … 100 mg
*Contains 11 mg sodium per capsule. Non-medicinal ingredients: microcrystalline cellulose, polyethylene oxide, silicon dioxide, sodium stearyl fumarate. Capsule: hypromellose, chlorophyll.
AOR Guarantees: that there is no more than 5 mg of S-lipoic acid per capsule, and that no ingredients not listed on the label have been added to the product. Contains no wheat, gluten, corn, nuts, dairy, soy, eggs, fish, shellfish or any animal byproduct.
Source: Pharmaceutical synthesis
What Is It?
R-lipoic acid and N-acetyl-cysteine provide exceptional antioxidant coverage, and the multitude of health benefits derived from this combination is astounding. Lipoic acid and NAC tend to be very short-lived in the blood. R + NAC SR is specially formulated to ensure greater stability and accessibility to the body than conventional lipoic acid and NAC supplements. It is designed to provide a sustained release of these nutrients over 8 hours, providing continuous resistance to free radical damage and numerous other health benefits.
What Does It Do?
Primary Uses: R-Lipoic acid provides antioxidant protection in the mitochondria and also helps to reduce the damaging effects of age. NAC is a highly efficient form of cysteine. Cysteine is the most important precursor for glutathione (GSH), one of the body's hardest working antioxidants. R-Lipoic acid and glutathione recycle each other and other antioxidants, keeping them fighting off free-radicals longer.
Secondary Uses: Both R-lipoic acid and NAC play roles in cardiovascular health, neurological protection, heavy metal chelation, blood sugar management, liver protection and more.
Who Should Take It?
R + NAC SR is the perfect duo for those looking for continual antioxidant protection and anti-aging benefits around the clock.
Take 1 capsule three times daily with protein-containing meals, or as directed by a qualified health care practitioner.
D, Breslow JL. Lipoproteins (a) reduction by N-acetylcysteine.(1991).The Lancet; 337: 203-4.
De Flora S, Grassi C, Carati L. Attention of influenza symptomatology and improvement of cell-mediated immunity with long-term NAC treatment. Eur. Respir J. (1997).10: 1535-1541.
Flanagan, R. Use of N-Acetyl cysteine in clinical toxicology. AM.J. Med. (1991).91: 131-9.
Hagen TM, Ingersoll RT, Lykkesfeldt J, Liu J, Wehr CM, Vinarsky V, Bartholomew JC, Ames AB. “
(R)-alpha-lipoic acid-supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate.”
FASEB J. 1999 Feb; 13(2): 411-8
Hagen TM, Vinarsky V, Wehr CM, Ames BN. “
(R)-alpha-lipoic acid reverses the age-associated increase in susceptibility of hepatocytes to tert-butylhydroperoxide both in vitro and in vivo.”
Antioxid Redox Signal. 2000 Fall; 2(3): 473-83.
Lockhart B, Jones C, Cuisinier C, Villain N, Peyroulan D, Lestage P. “
Inhibition of L-homocysteic acid and buthionine sulphoximine-mediated neurotoxicity in rat embryonic neuronal cultures with alpha-lipoic acid enantiomers.”
Brain Res. 2000 Feb 14; 855(2): 292-7.
Lorber A, et al. Clinical application for heavy metal-complexing potential of N-Acetyl-cystene. J. Clin. Pharmacol. (1973). 13: 332-336.Gavish
Streeper RS, Henriksen EJ, Jacob S, Hokama JY, Fogt DL, Tritschler HJ. “
Differential effects of lipoic acid stereoisomers on glucose metabolism in insulin-resistant skeletal muscle.”
Am J Physiol. 1997 Jul; 273(1 Pt 1): E185-91.
Suh J, Rocha A, Shigeno E, Frei B, Hagen TM. “
(R)-alpha-lipoic acid supplementation of old rats decreases age-dependent accumulation of iron and ascorbate depletion in brain.”
AGE. 1999 Jul; 22(3): 121(Abs 19).
Disclaimer: This content is subject to change. The information is intended to inform and educate; it does not replace the medical evaluation, advice, diagnosis or treatment by a healthcare professional. www.nhpassist.com © 2014 NDAssist Inc. and/or its affiliates. All rights reserved.